Home
Aarey Drugs & Pharmaceuticals Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Faarey-drugs-pharmaceuticals-ltd.png&w=128&q=75)
Aarey Drugs & Pharmaceuticals Ltd
NSE: AAREYDRUGS
PE
Key Highlights
- The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 18.8 as of 13 Feb 13:13 PM .
- The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 5.4 on March 2020 to 26.8 on March 2024 . This represents a CAGR of 37.77% over 5 years.
- The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 47.09 as of 13 Feb 13:01 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd
Company Fundamentals for Aarey Drugs & Pharmaceuticals Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Faarey-drugs-pharmaceuticals-ltd.png&w=128&q=75)
Aarey Drugs & Pharmaceuticals Ltd
NSE: AAREYDRUGS
Share Price
Market Price of Aarey Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 46.5 |
11 Feb 2025 | 46.5 |
10 Feb 2025 | 49.4 |
07 Feb 2025 | 49.38 |
06 Feb 2025 | 48.23 |
05 Feb 2025 | 47.74 |
04 Feb 2025 | 47.15 |
03 Feb 2025 | 49.49 |
01 Feb 2025 | 48.42 |
31 Jan 2025 | 48.01 |
SWOT Analysis Of Aarey Drugs & Pharmaceuticals Ltd
BlinkX Score for Aarey Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Aarey Drugs & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Aarey Drugs & Pharmaceuticals Ltd | 129.99 | 18.83 |
Sun Pharmaceuticals Industries Ltd | 406363 | 34.5 |
Divis Laboratories Ltd | 158396 | 76.6 |
Cipla Ltd | 117088 | 23.5 |
Torrent Pharmaceuticals Ltd | 103663 | 55.7 |
Dr Reddys Laboratories Ltd | 101458 | 18.9 |
Company | |
---|---|
Aarey Drugs & Pharmaceuticals Ltd | 129.99 |
Sun Pharmaceuticals Industries Ltd | 406363 |
Divis Laboratories Ltd | 158396 |
Cipla Ltd | 117088 |
Torrent Pharmaceuticals Ltd | 103663 |
Dr Reddys Laboratories Ltd | 101458 |
PE Ratio of Aarey Drugs & Pharmaceuticals Ltd Explained
₹129.99
Market cap
₹6
Earnings
18.8X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Aarey Drugs & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aarey Drugs & Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Aarey Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Aarey Drugs & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd
About Aarey Drugs & Pharmaceuticals Ltd
- Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
- In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
- Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
- The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.
Aarey Drugs & Pharmaceuticals Ltd News Hub
Aarey Drugs & Pharmaceuticals standalone net profit rises 72.22% in the June 2024 quarter
Net profit of Aarey Drugs & Pharmaceuticals rose 72.22% to Rs 1.24 crore in the quarter ended June 2
Read more
16 Aug 24
Aarey Drugs & Pharmaceuticals to hold board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 Aug
Read more
10 Aug 24
Aarey Drugs & Pharmaceuticals schedules AGM
Aarey Drugs & Pharmaceuticals announced that the 34th Annual General Meeting (AGM) of the company wi
Read more
19 Sept 24
Aarey Drugs & Pharmaceuticals to conduct board meeting
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 Octo
Read more
25 Sept 24